UBS AM
CANO

UBS AM’s Cano Health, Inc. CANO Stock Holding History

UBS AM’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,977
Closed -$50.1K – 2637
2023
Q3 		$50.1K Hold
1,977
– – ﹤0.01% 2579
2023
Q2 		$180K Hold
1,977
– – ﹤0.01% 2583
2023
Q1 		$180K Hold
1,977
– – ﹤0.01% 2583
2022
Q4 		$271K Hold
1,977
– – ﹤0.01% 2360
2022
Q3 		$1.71M Sell
1,977
-177
-8% -$111K ﹤0.01% 1681
2022
Q2 		$944K Buy
2,154
+243
+13% +$127K ﹤0.01% 1999
2022
Q1 		$1.21M Buy
1,911
+640
+50% +$403K ﹤0.01% 2032
2021
Q4 		$1.13M Buy
+1,271
New +$1.34M ﹤0.01% 2149

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM's CANO Position: Q4 2023 in Review

UBS AM sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 1,977 shares — an estimated $50.1K sold.

UBS AM first reported a position in CANO in Q4 2021 and held it in 8 quarters. The position peaked at $1.71M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • UBS AM reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • UBS AM sold 1,977 Cano Health, Inc. shares in Q4 2023, an estimated $50.1K.
  • UBS AM first reported a position in Cano Health, Inc. in Q4 2021 and held it in 8 quarters.
  • UBS AM's Cano Health, Inc. position peaked at $1.71M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.